US Prescription Sales Up in 2009; Top Therapy Areas Reflected in Thought Leader Select Projects

IMS Health reports a 5.1 percent increase in U.S. prescription sales in 2009. Demand for prescription drugs (new therapies and refills) as well as new treatment options for cancer, thrombosis and atrial fibrillation, and new generic treatment options drove growth in the year immediately preceding. Top therapy areas in 2009 include antipsychotics, lipid regulators, proton pump inhibitors, antidepressants, and anti-neoplastic monoclonal antibodies.

Thought Leader Select is pleased to have helped companies strengthen relationships with key opinion leaders (KOLs) and clinical investigators in 40% of the major therapeutic areas driving industry growth in 2009. Thought Leader Select has identified, profiled, and provided engagement and deployment recommendations for more than 1000 KOLs in the areas of insulin analogs, anti-platelets, GI and inflammatory, seizure disorders, erythropoietins, and anti-arthritic/biologic response modifiers.

Read the full report here.

More Posts

New White Paper on Patient Engagement

Technological and cultural forces are shifting the expectations that patients bring to their healthcare. Armed with the ever-growing availability of information (and misinformation) on the

New White Paper on Building Speakers Bureaus

The pharmaceutical industry has long used speakers bureaus and their associated meetings and events to educate healthcare providers (HCPs) about drug therapies and the diseases those drugs

Focus on Micro-Influencers

By Brian Castle, Digital Insights Lead Influencers and micro-influencers both play a key role in medical innovation and communication. Let’s discuss the difficult task of

Share:

Send Us A Message